Health Care & Life Sciences » Biotechnology | Onconova Therapeutics Inc.

Onconova Therapeutics Inc. | Ownership

Companies that own Onconova Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
683 Capital Management LLC
14,503,169
17.04%
11,838,235
0.71%
06/30/2018
Tyndall Management LLC
12,244,080
14.39%
10,147,058
71.53%
06/30/2018
Ecor1 Capital LLC
7,500,000
8.81%
7,500,000
0.34%
06/30/2018
Point72 Asset Management LP
3,600,000
4.23%
3,600,000
0.01%
06/30/2018
Kepos Capital LP
3,000,000
3.53%
3,000,000
0.06%
06/30/2018
Armistice Capital LLC
1,688,235
1.98%
340,735
0.06%
06/30/2018
Renaissance Technologies LLC
819,712
0.96%
672,312
0%
06/30/2018
The Vanguard Group, Inc.
574,367
0.68%
230,666
0%
06/30/2018
DRW Securities LLC
150,000
0.18%
150,000
0%
06/30/2018
Geode Capital Management LLC
145,487
0.17%
145,487
0%
06/30/2018

About Onconova Therapeutics

View Profile
Address
375 Pheasant Run
Newtown Pennsylvania 18940
United States
Employees -
Website http://www.onconova.com
Updated 07/08/2019
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.